Cargando…
NLRP3 inflammasome activation By 17β-estradiol is a potential therapeutic target in hepatocellular carcinoma treatment
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and it mostly arises as a consequence of persistent chronic inflammation. Recently, NLRP3 inflammasome has caught the attention of many research groups due to its involvement in different types of cancer. However, its direct...
Autores principales: | Awwad, Sara F., Assaf, Raymonde H., Emam, Ahmed A., Fouad, Amgad A., Arafa, Lamiaa F., El-Hanafy, Aya A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918588/ https://www.ncbi.nlm.nih.gov/pubmed/36763290 http://dx.doi.org/10.1007/s12032-022-01945-z |
Ejemplares similares
-
NLRP3 Inflammasome Activation in the Brain after Global Cerebral Ischemia and Regulation by 17β-Estradiol
por: Thakkar, Roshni, et al.
Publicado: (2016) -
The role of NLRP3 inflammasome in hepatocellular carcinoma
por: Zhao, Huijie, et al.
Publicado: (2023) -
Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer
por: Tezcan, Gulcin, et al.
Publicado: (2021) -
The Role of NLRP3 Inflammasome in Pericarditis: Potential for Therapeutic Approaches
por: Mauro, Adolfo G., et al.
Publicado: (2021) -
NLRP3 Inflammasome as Therapeutic Targets in Inflammatory Diseases
por: Prakash, Annamneedi Venkata, et al.
Publicado: (2023)